Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy.
Grossmann, Mathis
Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy. [electronic resource] - The Medical journal of Australia Mar 2011 - 301-6 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1326-5377
10.5694/j.1326-5377.2011.tb02979.x doi
Absorptiometry, Photon
Aged
Androgen Antagonists--adverse effects
Antineoplastic Agents, Hormonal--adverse effects
Bone Density--drug effects
Combined Modality Therapy
Diphosphonates--therapeutic use
Exercise--physiology
Humans
Life Style
Male
Middle Aged
Osteoporosis--chemically induced
Osteoporotic Fractures--diagnosis
Practice Guidelines as Topic
Prognosis
Prostatic Neoplasms--drug therapy
Risk Assessment
Treatment Outcome
Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy. [electronic resource] - The Medical journal of Australia Mar 2011 - 301-6 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1326-5377
10.5694/j.1326-5377.2011.tb02979.x doi
Absorptiometry, Photon
Aged
Androgen Antagonists--adverse effects
Antineoplastic Agents, Hormonal--adverse effects
Bone Density--drug effects
Combined Modality Therapy
Diphosphonates--therapeutic use
Exercise--physiology
Humans
Life Style
Male
Middle Aged
Osteoporosis--chemically induced
Osteoporotic Fractures--diagnosis
Practice Guidelines as Topic
Prognosis
Prostatic Neoplasms--drug therapy
Risk Assessment
Treatment Outcome